trial · primary record
FDC tiotropium / salmeterol
Pulmonary Disease, Chronic Obstructive
| Phase | Phase 3 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 220 |
| Primary completion | 2008-11-21 |
| Primary endpoint | Change From Baseline in Trough Forced Expiratory Volume in One Second (FEV1) at the End of the 12-week Treatment Period |
| Registry ID | NCT00662740 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:30.536Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT00662740
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.